You searched for tofacitinib

DDW 2022

Tofacitinib, Vedolizumab Effective for UC Post-Anti-TNF Agent Failure

May 24, 2022

Researchers compared the effectiveness of tofacitinib and vedolizumab among patients with UC who had experienced anti-TNF failure.

News

CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis

January 31, 2022

Incidences of major adverse cardiovascular events, cancers higher with tofacitinib versus TNF inhibitor; criteria for noninferiority not met

ACR 2019, News

Few Serious Infections in Offspring Exposed to Non-TNFi Biologics, Tofacitinib

November 11, 2019

Researchers compared the risk for serious infections in offspring of mothers with chronic inflammatory diseases who received non-TNFi biologics or tofacitinib during pregnancy vs offspring who were unexposed, but exposed to TNFi in utero.

Musculoskeletal Disorders

Tofacitinib Benefits Sustained for Two Years in Patients With RA

February 4, 2019

The clinical benefits of tofacitinib in combination with methotrexate are sustained over 2 years among patients with rheumatoid arthritis (RA), according to a study published online January 22 in Arthritis & Rheumatology.

ACR/ARHP 2018 Annual Meeting

Venus Thromboembolism Risk Assessed With Tofacitinib, TNF Inhibitors

October 24, 2018

Although the incidence rate of venous thromboembolism was numerically higher in patients treated with tofacitinib vs TNF inhibitors, the risk was not statistically significant.

ACR/ARHP 2018 Annual Meeting

RA Remission Compared for Tofacitinib Alone vs. Steroid Plus Tofacitinib Tx

October 22, 2018

The results support combination therapy with intra-articular steroid injections and tofacitinib to achieve clinical and radiographic remission in patients with early rapid radiographic progression RA.

ACR/ARHP 2018 Annual Meeting

Clinical Efficacy of Tofacitinib Once-Daily vs Twice-Daily Examined in RA

October 22, 2018

Tofacitinib extended release has comparable clinical efficacy to tofacitinib administered twice daily.

News

Tofacitinib + Phototherapy May Be Beneficial for Vitiligo Treatment

February 6, 2018

Case reports describe repigmentation of vitiligo with facial involvement in Hispanic woman, white man

News

Tofacitinib Efficacy Investigated in Patients With Psoriatic Arthritis

October 20, 2017

Tofacitinib is superior for patients with inadequate response to TNF inhibitors or conventional DMARDs

News

Tofacitinib Assessed for Efficacy in Nail Psoriasis

June 20, 2017

The researchers found that significantly more patients receiving tofacitinib 5mg and tofacitinib 10mg versus placebo achieved a ≥50% reduction in the Nail Psoriasis Severity Index (NAPSI) score from baseline (NAPSI50)

Active Filters

Your search for tofacitinib returned 38 results

Sort Results:

Tofacitinib, Vedolizumab Effective for UC Post-Anti-TNF Agent Failure

CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis

Few Serious Infections in Offspring Exposed to Non-TNFi Biologics, Tofacitinib

Tofacitinib Benefits Sustained for Two Years in Patients With RA

Venus Thromboembolism Risk Assessed With Tofacitinib, TNF Inhibitors

RA Remission Compared for Tofacitinib Alone vs. Steroid Plus Tofacitinib Tx

Clinical Efficacy of Tofacitinib Once-Daily vs Twice-Daily Examined in RA

Tofacitinib + Phototherapy May Be Beneficial for Vitiligo Treatment

Tofacitinib Efficacy Investigated in Patients With Psoriatic Arthritis

Tofacitinib Assessed for Efficacy in Nail Psoriasis